ERP timeline
Every ERP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| ERP-2605-E9865 | Survodutide | 11 May 2026 | 2026-Q3 | 2 | 98.31 | 0.14 | 98.54 | +0.23 | |
| ERP-2604-W9463 | Tesamorelin | 17 Apr 2026 | 2026-Q3 | 1 | 99.02 | n<2 | 99.00 | -0.02 | |
| ERP-2603-D1065 | Mazdutide | 03 Mar 2026 | 2026-Q2 | 4 | 97.77 | 0.35 | 97.97 | +0.20 | |
| ERP-2601-X8820 | Glucagon | 24 Jan 2026 | 2026-Q1 | 2 | 98.55 | 0.27 | 98.17 | -0.38 | |
| ERP-2601-F9816 | GHK-Cu | 16 Jan 2026 | 2026-Q2 | 10 | 98.65 | 0.91 | 99.00 | +0.35 | |
| ERP-2601-P8985 | Liraglutide | 15 Jan 2026 | 2026-Q2 | 1 | 99.25 | n<2 | 99.50 | +0.25 | |
| ERP-2601-P8786 | Humanin (HNG) | 03 Jan 2026 | 2026-Q1 | 6 | 98.73 | 0.66 | 99.00 | +0.27 | |
| ERP-2512-T9616 | Tirzepatide | 12 Dec 2025 | 2026-Q2 | 3 | 98.72 | 0.77 | 98.46 | -0.26 | |
| ERP-2512-G9157 | Semax | 10 Dec 2025 | 2026-Q1 | 5 | 99.46 | 0.84 | 99.36 | -0.10 | |
| ERP-2511-L9306 | TB-500 | 10 Nov 2025 | 2025-Q4 | 7 | 99.24 | 1.17 | 98.57 | -0.67 | |
| ERP-2509-K8683 | PEG-MGF | 22 Sep 2025 | 2026-Q1 | 6 | 98.22 | 0.81 | 98.30 | +0.08 | |
| ERP-2509-K9340 | TB-500 | 10 Sep 2025 | 2025-Q4 | 11 | 99.37 | 0.63 | 99.82 | +0.45 | |
| ERP-2508-R9614 | Kisspeptin-10 | 18 Aug 2025 | 2025-Q4 | 5 | 99.07 | 0.35 | 98.49 | -0.58 | |
| ERP-2508-S8293 | Semaglutide | 05 Aug 2025 | 2025-Q3 | 6 | 99.38 | 0.51 | 99.00 | -0.38 | |
| ERP-2508-M9453 | MOTS-c | 01 Aug 2025 | 2025-Q3 | 12 | 99.01 | 1.17 | 98.72 | -0.29 | |
| ERP-2507-A8576 | CJC-1295 with DAC | 23 Jul 2025 | 2025-Q4 | 1 | 99.45 | n<2 | 99.23 | -0.22 | |
| ERP-2506-E9178 | CJC-1295 with DAC | 29 Jun 2025 | 2025-Q3 | 8 | 99.10 | 0.44 | 98.80 | -0.30 | |
| ERP-2506-C9403 | Retatrutide | 16 Jun 2025 | 2025-Q3 | 1 | 98.91 | n<2 | 99.14 | +0.23 | |
| ERP-2506-B9718 | CJC-1295 (no DAC) | 15 Jun 2025 | 2025-Q4 | 10 | 98.87 | 0.42 | 99.32 | +0.45 | |
| ERP-2505-U8938 | Ipamorelin | 16 May 2025 | 2025-Q4 | 9 | 99.62 | 0.46 | 99.90 | +0.28 | SHARED BULK |
| ERP-2504-G9130 | Kisspeptin-10 | 29 Apr 2025 | 2025-Q2 | 2 | 98.62 | 0.02 | 98.38 | -0.24 | SHARED BULK |
| ERP-2503-A9615 | Oxytocin | 15 Mar 2025 | 2025-Q2 | 5 | 99.09 | 0.13 | 99.56 | +0.47 | |
| ERP-2502-S9437 | Ipamorelin | 16 Feb 2025 | 2025-Q3 | 12 | 99.03 | 0.98 | 98.94 | -0.09 | |
| ERP-2502-P9890 | BPC-157 | 11 Feb 2025 | 2025-Q1 | 4 | 99.86 | 0.29 | 99.90 | +0.04 | |
| ERP-2502-K9538 | Semaglutide | 11 Feb 2025 | 2025-Q3 | 2 | 98.88 | 0.42 | 98.98 | +0.10 | |
| ERP-2501-B8503 | MGF | 07 Jan 2025 | 2025-Q1 | 2 | 98.85 | 0.68 | 99.63 | +0.78 | |
| ERP-2411-Y8614 | Follistatin-344 | 10 Nov 2024 | 2025-Q1 | 1 | — | n<2 | 98.00 | — | |
| ERP-2408-R9378 | GHRP-6 | 26 Aug 2024 | 2024-Q3 | 9 | 98.83 | 0.86 | 99.00 | +0.17 | |
| ERP-2408-G8748 | Pemvidutide | 23 Aug 2024 | 2025-Q1 | 1 | 99.66 | n<2 | 99.90 | +0.24 | |
| ERP-2408-G9396 | Ipamorelin | 11 Aug 2024 | 2024-Q3 | 1 | 99.68 | n<2 | 99.46 | -0.22 | |
| ERP-2406-F9295 | Ipamorelin | 30 Jun 2024 | 2024-Q3 | 3 | 99.41 | 0.35 | 99.71 | +0.30 | |
| ERP-2406-E9182 | Tirzepatide | 25 Jun 2024 | 2024-Q3 | 11 | 98.19 | 1.25 | 98.35 | +0.16 | |
| ERP-2406-C9933 | Gonadorelin | 19 Jun 2024 | 2024-Q3 | 9 | 99.80 | 0.33 | 99.72 | -0.08 | |
| ERP-2405-P9008 | NAD+ | 20 May 2024 | 2024-Q4 | 1 | 97.82 | n<2 | 98.51 | +0.69 | |
| ERP-2402-U8706 | BPC-157 | 26 Feb 2024 | 2024-Q3 | 6 | 99.08 | 0.26 | 99.12 | +0.04 | |
| ERP-2402-D9383 | BPC-157 | 01 Feb 2024 | 2024-Q2 | 9 | 99.44 | 0.95 | 99.29 | -0.15 | |
| ERP-2401-K8556 | TB-500 | 26 Jan 2024 | 2024-Q2 | 5 | 99.28 | 0.34 | 99.19 | -0.09 | |
| ERP-2401-D8257 | Tirzepatide | 19 Jan 2024 | 2024-Q2 | 12 | 98.54 | 0.52 | 98.62 | +0.08 |